Cargando…
Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients
Prediction of survival for patients with metastatic breast cancer is often inaccurate and may be helped by new biological parameters. Tumour growth being angiogenesis-dependent, it has been hypothesised that the assessment of angiogenic factor production might reflect the clinical behaviour of cance...
Autores principales: | Bachelot, T, Ray-Coquard, I, Menetrier-Caux, C, Rastkha, M, Duc, A, Blay, J-Y |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377148/ https://www.ncbi.nlm.nih.gov/pubmed/12771987 http://dx.doi.org/10.1038/sj.bjc.6600956 |
Ejemplares similares
-
Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome
por: Bachelot, T, et al.
Publicado: (2006) -
A comparison of serum and plasma levels of vascular endothelial growth factor during the menstrual cycle in healthy female volunteers
por: McIlhenny, C, et al.
Publicado: (2002) -
Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer
por: Edwards, J, et al.
Publicado: (2003) -
Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?
por: Ménétrier-Caux, Christine, et al.
Publicado: (2019) -
Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer
por: Dirix, L Y, et al.
Publicado: (2002)